Evidence map›Paper›PMID 28437435›Full record

ArticlePloS one2017

Infective respiratory syncytial virus is present in human cord blood samples and most prevalent during winter months.

Angela Mary Fonceca, Abha Chopra, Avram Levy, Paul Stanton Noakes, Matthew Wee-Peng Poh, Natasha Leanne Bear, Susan Prescott, Mark Lloyd Everard

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Angela Mary FoncecaSchool of Paediatrics and Child Health, University of Western Australia, Subiaco, Western Australia Australia.ORCID http://orcid.org/0000-0002-5532-7997
Abha ChopraInstitute of Immunity and Infectious Diseases (IIID), Murdoch University, Murdoch, Western Australia, Australia.
Avram LevyPathWest Laboratory Medicine WA, Queen Elizabeth II Medical Centre, Nedlands, Western Australia, Australia.
Paul Stanton NoakesTelethon Kids Institute, Subiaco, Western Australia, Australia.
Matthew Wee-Peng PohSchool of Paediatrics and Child Health, University of Western Australia, Subiaco, Western Australia Australia.
Natasha Leanne BearChild and adolescent health service (CAHS), Department of Health, Subiaco, Western Australia, Australia.
Susan PrescottSchool of Paediatrics and Child Health, University of Western Australia, Subiaco, Western Australia Australia.
Mark Lloyd EverardSchool of Paediatrics and Child Health, University of Western Australia, Subiaco, Western Australia Australia.
The University of Western Australia · AUThe Kids Research Institute Australia · AUGovernment of Western Australia Department of Health · AUMurdoch University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHuman respiratory syncytial virus (RSV) remains the most common cause of severe lower respiratory tract disease amongst infants, and continues to cause annual epidemics of respiratory disease every winter worldwide. Demonstrating placental transmission of viable RSV in human samples is a major paradigm shift in respiratory routes considered likely for RSV transmission.

methodsDroplet digital PCR (ddPCR) was used to identify RSV present in cord blood mononucleocytes (CBM). CBMs testing positive for RSV were treated with phytohemagglutinin (PHA), PHA and nitric oxide (NO) or PHA, NO and palivizumab, and co-cultured with HeLa cell monolayers. Subsequent immuno-staining for RSV was used to visualize infective viral plaques.

resultsRSV was detected in 26 of 45 samples (57.7%) by ddPCR. CBM's collected in winter were more likely to test positive for RSV (17/21 samples, risk = 80%, OR = 7.08; 95% CI 1.80-27.80; p = 0.005) compared to non-winter months (9/24 samples, 37.5%). RSV plaques were observed in non-treated and treated co-cultured HeLa monolayers.

conclusionsDemonstrating active RSV in CBMs suggests in utero transmission of infective virus to the fetus without causing overt disease. This is likely to have an important impact on immune development as well as future virus-host interactions, thereby warranting further investigation.

Indexed as

Infectious Disease Transmission, VerticalSeasonsAdolescentAdultFemaleFetal BloodHumansMiddle AgedRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsYoung Adult

Identifiers

PMID28437435
PMCPMC5402929
OpenAlexW2610042854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.